Each of our companies has the potential to change the world

We give them the chance.

we SHINE A LIGHT WHERE OTHERS DON’T

The future is already out there. We scour the edges of what’s possible so we can find it first.

TO BALANCE RISK… AND REVOLUTIONARY

We make smart bets on where the next big thing will come from. When we’re right, financial success is just the start.

WHEN WE BRING THE RIGHT INGREDIENTS TOGETHER,
THE RESULTS SHINE BRIGHT

Here at Lux, everything we do is more than the sum of its parts

We bring together the sharpest minds and the most advanced technology

amplifying transformational ideas into radical change

WHEN WE BRING THE RIGHT INGREDIENTS TOGETHER
THE RESULTS SHINE BRIGHT

We bring together the sharpest minds and the most advanced technology

amplifying transformational ideas into radical change

WE’RE LOOKING FOR BIG IDEAS
(AND THE BIG BRAINS BEHIND THEM)

We partner with companies and founders trying to change the world, who want to upend paradigms, not just chase incremental progress.

FOUNDERS WHO SEE THE FUTURE

We’re looking for leaders with a vision, who see a radically different future and know how to make it happen. They’re equal parts mad scientist and business mastermind: walking, talking Venn diagrams ready to change everything.
neuroscience
biology
defense
sensing

COMPANIES THAT MAKE IT REAL

We invest in companies that see radical potential in what they do. Founders who see reshaping a single industry as table stakes.
And teams that see failure as just a challenge to find a new path.
neuroscience
manufacturing
biology
defense
data & ai
robotics
sensing
space
manufacturing
data & ai
robotics
space

The Basics

Over the past two decades, Lux has expanded from our New York City roots to Silicon Valley, and built a firm with over $5 billion AUM and more than 30 full-time professionals, with a wide spectrum of technical backgrounds and the versatility to invest at any stage, from $100,000 to $100 million.

The Basics

Over the past two decades, Lux has expanded from our New York City roots to Silicon Valley, and built a firm with over $5 billion AUM and more than 30 full-time professionals, with a wide spectrum of technical backgrounds and the versatility to invest at any stage, from $100,000 to $100 million.

get in touch

Whether you want to learn more, pitch us, or just have a chat, we’d love to hear from you.

say
hello

Just want to get in touch? Shoot us an email at info@luxcapital.com and we’ll see how we can help.

get some background

Want to see what we’re up to? Check out what the rest of the world’s been saying.

What we're up to

Pivotal Pivots

February 24, 2024
Danny Crichton

The global policeman suddenly had a far larger and more sophisticated band of criminals to thwart. Yet, the way in which America conducts its foreign policy has not changed.

continue reading

“I am basically a cosmic Fluke” and the chaos of science, policy, and human narratives

February 21, 2024
Danny Crichton
Latest Press
February 29, 2024
Lux Capital's Grace Isford Sees Unprecedented AI Demand in NYC
Caroline Hyde and Ed Ludlow
Bloomberg
February 21, 2024
Lux Q4 2023 Report
Josh Wolfe
February 1, 2024
Coris raises $3.7M, sets sights on AI-driven paradigm shift in SMB risk management
Michael Nunez
VentureBeat
January 16, 2024
Our Investment in Japan’s Sakana AI 魚 to build nature-inspired AI foundation models
Grace Isford
January 16, 2024
AI Startup Sakana Raises $30 Million to Build Smaller AI Models
Rachel Metz
Bloomberg
January 16, 2024
Top ex-Google researchers raise $30 mln for Tokyo-based AI lab
Anna Tong
Reuters
January 11, 2024
Investing in Health and Science Tech in 2024
Ed Ludlow and Caroline Hyde
Bloomberg
December 30, 2023
The Pentagon Road to Venture Capital
Eric Lipton
The New York Times
December 29, 2023
The Information’s 2023 Exit Survey of Tech Leaders
The Information Staff
The Information
December 7, 2023
Wall Street Puts a ‘Sell’ on Its China Holdings
Lingling Wei
The Wall Street Journal
December 5, 2023
Why this tech-funding VC is optimistic about science but skeptical about the human condition
Grace Snelling
Fast Company
December 4, 2023
Lux Q3 2023 Report
Josh Wolfe
November 28, 2023
30 Under 30 Venture Capital 2024: Meet The Young Investors Backing Next-Gen Startups From AI To Space Tech
Alex Konrad, Dean Sterling Jones and Alex York
Forbes
November 21, 2023
Lux Capital Co-Founder: Microsoft Wins the OpenAI Debacle
Ed Ludlow and Caroline Hyde
Bloomberg
October 3, 2023
A More Perfect Union Could Be Good for Workers and Investors
Josh Wolfe
Barron's
October 2, 2023
The 68 most important VCs in New York, according to other VCs
Vishal Persaud, Darius Rafieyan, Leena Rao, Madeline Renbarger and Samantha Stokes
Insider
September 7, 2023
Startup investors are fueling a boom in U.S. defense tech as China standoff opens doors at home
Lauren Feiner
CNBC
September 1, 2023
Paging Dr. GPT? Tech Investors Bet AI Finally Poised to Transform Health Care
Priya Anand
Bloomberg
August 31, 2023
VC Spotlight: The Rise of Defense Tech
Ed Ludlow
Bloomberg
August 24, 2023
Generative AI has enhanced cybersecurity weapons, but defenders can still claim a lot of value
Yadin Arnon
August 19, 2023
Silicon Valley start-ups revive listing plans as Arm reignites IPO market
George Hammond and Tabby Kinder
Financial Times
August 18, 2023
Lux Q2 2023 Report
Josh Wolfe
August 17, 2023
If labor unions win, it'll be a tailwind for healthcare services
Morgan Brennan
CNBC
August 10, 2023
Why Bill Gurley & Josh Wolfe Think VCs Won't Deploy All Their Dry Powder Anytime Soon
Eric Newcomer
August 9, 2023
American VCs Fought Back Strict Biden Rules on China Investments. But More May Be Coming
Sarah McBride and Lizette Chapman
Bloomberg
August 2, 2023
Our Investment in Reflex: Building Web Apps in Pure Python
Grace Isford
August 1, 2023
Lots of Activity, Interest in Women's Health Startups
Ed Ludlow
Bloomberg
July 31, 2023
There’s no better time to be invested in health care stocks, says Lux Capital’s Deena Shakir
Morgan Brennan and Jon Fortt
CNBC
July 31, 2023
How Silicon Valley is helping the Pentagon in the AI arms race
Tabby Kinder
Financial Times
July 31, 2023
There’s no better time to be invested in health care stocks
Morgan Brennan and Jon Fortt
CNBC